InMode Ltd. is rated a Buy, offering strong growth, innovation, global expansion, and attractive value. Learn more about INMD ...
YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...
Fintel reports that on October 10, 2025, Canaccord Genuity maintained coverage of InMode (NasdaqGS:INMD) with a Hold recommendation. Analyst Price Forecast Suggests 8.62% Upside As of September 30, ...
Canaccord raised the firm’s price target on InMode (INMD) to $16 from $14 and keeps a Hold rating on the shares. The firm noted the announced preliminary Q3/25 results with revenues above estimates ...
IT white papers, webcasts, case studies, and much more - all free to registered TechRepublic members. Keeping all the various moving parts of a business running smoothly and on time requires a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results